What should be the Research Standard for Myocarditis with Covid Vaccines?

Study on prevalence of myocarditis in athletes with SARS-CoV-2 infection in May 2021. • 1:44

Private funding supported a comprehensive study on myocarditis risks. • 2:39

Covid-19 poses significant risks, including myocarditis even in non-severe cases. • 3:10

Vaccination of younger population aimed at preventing myocarditis risks. • 3:46

Myocarditis can also occur post-vaccination, necessitating research and vigilance. • 4:03

Study used four modalities to assess myocarditis in athletes with COVID-19. • 4:42

Research findings included subclinical myocarditis cases and residual damage post-infection. • 6:04

Question raised on lack of similar in-depth research for COVID-19 vaccinations in colleges. • 8:05

Critical need for research on myocarditis risk post Covid vaccinatio. • 8:34

Significant findings of myocarditis cases post Covid infectio. • 9:36

High risk of myocarditis post booster doses highlighted in recent stud. • 10:44

Concerns raised about scientific community’s reluctance to address risk. • 11:24